These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 19900407)

  • 1. Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.
    Yamakawa K; Izumi Y; Takeuchi H; Yamamoto N; Kume T; Akaike A; Takahashi R; Shimohama S; Sawada H
    Biochem Biophys Res Commun; 2010 Jan; 391(1):129-34. PubMed ID: 19900407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine.
    Moussa CE; Wersinger C; Tomita Y; Sidhu A
    Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C; Ridet JL; Schneider BL; Deglon N; Aebischer P
    Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10813-8. PubMed ID: 12122208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of dopamine-mediated alpha-synuclein-soluble oligomers requires methionine oxidation.
    Leong SL; Pham CL; Galatis D; Fodero-Tavoletti MT; Perez K; Hill AF; Masters CL; Ali FE; Barnham KJ; Cappai R
    Free Radic Biol Med; 2009 May; 46(10):1328-37. PubMed ID: 19248830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells.
    Gómez-Santos C; Ferrer I; Santidrián AF; Barrachina M; Gil J; Ambrosio S
    J Neurosci Res; 2003 Aug; 73(3):341-50. PubMed ID: 12868068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation.
    Bellucci A; Collo G; Sarnico I; Battistin L; Missale C; Spano P
    J Neurochem; 2008 Jul; 106(2):560-77. PubMed ID: 18410503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity.
    Colapinto M; Mila S; Giraudo S; Stefanazzi P; Molteni M; Rossetti C; Bergamasco B; Lopiano L; Fasano M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1294-300. PubMed ID: 16978583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein overexpression reduces gap junctional intercellular communication in dopaminergic neuroblastoma cells.
    Sung JY; Lee HJ; Jeong EI; Oh Y; Park J; Kang KS; Chung KC
    Neurosci Lett; 2007 Apr; 416(3):289-93. PubMed ID: 17337120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells.
    Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S
    Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotenone induces apoptosis via activation of bad in human dopaminergic SH-SY5Y cells.
    Watabe M; Nakaki T
    J Pharmacol Exp Ther; 2004 Dec; 311(3):948-53. PubMed ID: 15280438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis.
    Alberio T; Bossi AM; Milli A; Parma E; Gariboldi MB; Tosi G; Lopiano L; Fasano M
    FEBS J; 2010 Dec; 277(23):4909-19. PubMed ID: 20977677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z; Ferger B; Feldon J; Büeler H
    J Neurobiol; 2002 Oct; 53(1):1-10. PubMed ID: 12360578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell-based model of alpha-synucleinopathy for screening compounds with therapeutic potential of Parkinson's disease.
    Zhao DL; Zou LB; Zhou LF; Zhu P; Zhu HB
    Acta Pharmacol Sin; 2007 May; 28(5):616-26. PubMed ID: 17439717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation.
    Liu IH; Uversky VN; Munishkina LA; Fink AL; Halfter W; Cole GJ
    Glycobiology; 2005 Dec; 15(12):1320-31. PubMed ID: 16037493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.
    Purisai MG; McCormack AL; Langston WJ; Johnston LC; Di Monte DA
    Neurobiol Dis; 2005 Dec; 20(3):898-906. PubMed ID: 16006134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray expression analysis of human dopaminergic neuroblastoma cells after RNA interference of SNCA--a key player in the pathogenesis of Parkinson's disease.
    Häbig K; Walter M; Stappert H; Riess O; Bonin M
    Brain Res; 2009 Feb; 1256():19-33. PubMed ID: 19135032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy.
    Sultana Z; Paleologou KE; Al-Mansoori KM; Ardah MT; Singh N; Usmani S; Jiao H; Martin FL; Bharath MM; Vali S; El-Agnaf OM
    Neuroscience; 2011 Dec; 199():303-17. PubMed ID: 22056602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective loss of nigral dopamine neurons induced by overexpression of truncated human alpha-synuclein in mice.
    Wakamatsu M; Ishii A; Iwata S; Sakagami J; Ukai Y; Ono M; Kanbe D; Muramatsu S; Kobayashi K; Iwatsubo T; Yoshimoto M
    Neurobiol Aging; 2008 Apr; 29(4):574-85. PubMed ID: 17174013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.